Company: CERO
Filing Date: 2025-11-17
Form Type: NT 10-Q
Source: 0001213900-25-111295
Chunk: 1

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-11-17
Form: NT 10-Q
Chunk 1
---
 on Form 10-Q or subject distribution    
 report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and            |                                                                                       |
|   | -c | The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.                                      |                                                                                       |

<div align='center'>PART III — NARRATIVE</div>

State below in reasonable detail the reasons why
Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-CEN, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed
time period.

The management and accounting personnel of
CERo Therapeutics Holdings, Inc. (the “Company”) are finalizing the accounting for various recent transactions, including the
issuance of Series E Preferred Stock, sales of common stock under its equity line of credit and the conversion of a large number of
shares of Series D Preferred Stock. The Company’s independent registered public accounting firm is also finalizing its review
of such items. As a result of the pending finalization of these items, there will be a delay in the Company’s ability to
complete and file its Quarterly Report on Form 10-Q for the three-months ended September 30, 2025 (the “Quarterly
Report”) by the November 14, 2025 filing date applicable to smaller reporting companies without unreasonable effort and
expense. The Company anticipates that it will file the Quarterly Report no later than the fifth calendar day following the
prescribed filing date.

<div align='center'>PART IV — OTHER INFORMATION</div>

| (1) | Name and telephone number of person to contact in regard to this notification. |

| Andrew Kucharchuk |     |        650 |     | 407-2376          |
| (Name)            |     | -Area Code |     | -Telephone Number |

| (2) | Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s). ☒ Yes ☐ No |

| (3) | Is it anticipated that any significant change in results of